279 related articles for article (PubMed ID: 26358738)
21. Modified Si-Miao-San extract inhibits inflammatory response and modulates insulin sensitivity in hepatocytes through an IKKβ/IRS-1/Akt-dependent pathway.
Liu K; Luo T; Zhang Z; Wang T; Kou J; Liu B; Huang F
J Ethnopharmacol; 2011 Jul; 136(3):473-9. PubMed ID: 21296137
[TBL] [Abstract][Full Text] [Related]
22. The anti-inflammatory effect of exercise.
Petersen AM; Pedersen BK
J Appl Physiol (1985); 2005 Apr; 98(4):1154-62. PubMed ID: 15772055
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic potential of anti-IL-1β IgY in guinea pigs with allergic asthma induced by ovalbumin.
Wei-xu H; Qin X; Zhu W; Yuan-yi C; Li-feng Z; Zhi-yong L; Dan H; Xiao-mu W; Guo-zhu H
Mol Immunol; 2014 Mar; 58(1):139-49. PubMed ID: 24355520
[TBL] [Abstract][Full Text] [Related]
24. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics.
Suzuki K; Nakaji S; Yamada M; Totsuka M; Sato K; Sugawara K
Exerc Immunol Rev; 2002; 8():6-48. PubMed ID: 12690937
[TBL] [Abstract][Full Text] [Related]
25. Why do anti-inflammatory therapies fail to improve insulin sensitivity?
Gao ZG; Ye JP
Acta Pharmacol Sin; 2012 Feb; 33(2):182-8. PubMed ID: 22036866
[TBL] [Abstract][Full Text] [Related]
26. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.
Black PH
Med Hypotheses; 2006; 67(4):879-91. PubMed ID: 16781084
[TBL] [Abstract][Full Text] [Related]
27. The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus.
Daniele G; Guardado Mendoza R; Winnier D; Fiorentino TV; Pengou Z; Cornell J; Andreozzi F; Jenkinson C; Cersosimo E; Federici M; Tripathy D; Folli F
Acta Diabetol; 2014 Feb; 51(1):123-31. PubMed ID: 24370923
[TBL] [Abstract][Full Text] [Related]
28. Possible role of interleukin-1β in type 2 diabetes onset and implications for anti-inflammatory therapy strategies.
Zhao G; Dharmadhikari G; Maedler K; Meyer-Hermann M
PLoS Comput Biol; 2014 Aug; 10(8):e1003798. PubMed ID: 25167060
[TBL] [Abstract][Full Text] [Related]
29. [Rheumatoid arthritis, inflammation, and atherosclerosis].
Hürlimann D; Enseleit F; Ruschitzka F
Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of olmesartan and ramipril on inflammatory response after myocardial infarction in rats.
Sandmann S; Li J; Fritzenkötter C; Spormann J; Tiede K; Fischer JW; Unger T
Blood Press; 2006; 15(2):116-28. PubMed ID: 16754275
[TBL] [Abstract][Full Text] [Related]
31. Chrysin, an anti-inflammatory molecule, abrogates renal dysfunction in type 2 diabetic rats.
Ahad A; Ganai AA; Mujeeb M; Siddiqui WA
Toxicol Appl Pharmacol; 2014 Aug; 279(1):1-7. PubMed ID: 24848621
[TBL] [Abstract][Full Text] [Related]
32. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
Leiter LA; Lewanczuk RZ
Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
[TBL] [Abstract][Full Text] [Related]
33. Macrophages and islet inflammation in type 2 diabetes.
Eguchi K; Manabe I
Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():152-8. PubMed ID: 24003932
[TBL] [Abstract][Full Text] [Related]
34. DXXK exerts anti-inflammatory effects by inhibiting the lipopolysaccharide-induced NF-κB/COX-2 signalling pathway and the expression of inflammatory mediators.
Yu Y; Li X; Qu L; Chen Y; Dai Y; Wang M; Zou W
J Ethnopharmacol; 2016 Feb; 178():199-208. PubMed ID: 26571085
[TBL] [Abstract][Full Text] [Related]
35. Anti-inflammatory effects of carvacrol: evidence for a key role of interleukin-10.
Lima Mda S; Quintans-Júnior LJ; de Santana WA; Martins Kaneto C; Pereira Soares MB; Villarreal CF
Eur J Pharmacol; 2013 Jan; 699(1-3):112-7. PubMed ID: 23220159
[TBL] [Abstract][Full Text] [Related]
36. "Anti-inflammatory" drugs and their effects on type 2 diabetes.
Deans KA; Sattar N
Diabetes Technol Ther; 2006 Feb; 8(1):18-27. PubMed ID: 16472047
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-1 receptor antagonist: a new therapy for type 2 diabetes mellitus.
Akash MS; Shen Q; Rehman K; Chen S
J Pharm Sci; 2012 May; 101(5):1647-58. PubMed ID: 22271340
[TBL] [Abstract][Full Text] [Related]
38. Amelioration of streptozotocin-induced type 2 diabetes mellitus in Wistar rats by arachidonic acid.
Gundala NKV; Naidu VGM; Das UN
Biochem Biophys Res Commun; 2018 Jan; 496(1):105-113. PubMed ID: 29309791
[TBL] [Abstract][Full Text] [Related]
39. A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients.
Satoh-Asahara N; Sasaki Y; Wada H; Tochiya M; Iguchi A; Nakagawachi R; Odori S; Kono S; Hasegawa K; Shimatsu A
Metabolism; 2013 Mar; 62(3):347-51. PubMed ID: 23062489
[TBL] [Abstract][Full Text] [Related]
40. [Inflammation and diabetes].
Löbner K; Füchtenbusch M
MMW Fortschr Med; 2004 Sep; 146(35-36):32-3, 35-6. PubMed ID: 15540536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
